Chronic total occlusion percutaneous coronary intervention during the COVID-19 pandemic: Insights from the PROGRESS-CTO registry

Hellenic J Cardiol. 2021 Sep-Oct;62(5):372-373. doi: 10.1016/j.hjc.2021.05.005. Epub 2021 Jun 5.

¹ Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.
² Henry Ford Health System, Detroit, MI, USA.
³ Cleveland Clinic, Cleveland, OH, USA.
⁴ Meshalkin Novosibrisk Research Institute, Novosibirsk, Russia.
⁵ University Hospitals, Case Western Reserve University, Cleveland, OH, USA.
⁶ Minneapolis Heart Institute Foundation, Minneapolis, MN, USA; Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN, USA.
⁷ Minneapolis Heart Institute Foundation, Minneapolis, MN, USA; Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN, USA. Electronic address: esbrilakis@gmail.com.

No abstract available

Keywords: COVID-19; angioplasty and stenting; coronary artery disease; coronary occlusion; percutaneous coronary intervention.

Publication types